- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01110304
Acromio-clavicular Dislocation Type III - Conservative Treatment Versus Surgical Hook Plate Treatment
Acromio-clavicular Joint Dislocation Type III. Conservative Treatment Compared to Surgical Management With 3.5mm Clavicle Hook Plate. A Prospective Randomized Study
Acromio-clavicular (AC) joint dislocation corresponds to 8.6% of all joint dislocations and represents a major injury to the shoulder girdle. The nature of the treatment is decided according to the severity of the lesion.
The purpose of this study is to determine whether the surgical treatment is required or not for type III AC joint dislocations.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1J 1Z4
- Recruiting
- CHA-Pavillon Enfant-Jésus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- men or women ≥ 18 years-old;
- AC joint dislocation type III with Zanca X-ray view demonstrating CC distance of 200%;
- trauma-surgery delay of less than 14 days;
- consent form signed.
Exclusion Criteria:
- AC joint dislocation type I, II, IV, V or VI;
- associated neuro-vascular damage;
- men or women > 60 years-old;
- open dislocation;
- local skin damage;
- dislocation in a polytrauma patient;
- floating shoulder;
- fracture of the ipsilateral or controlateral arm or shoulder girdle;
- fracture of the coracoid process of the scapula;
- history of previous surgery to the shoulder;
- medical condition preventing surgery;
- men or women unfit to consent;
- any other condition that make the examinator thinks that the follow up would be problematic.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Conservative treatment
Patients selected for this treatment will wear a light brace for pain release and analgesics will be prescribed.
|
Patients selected for this treatment will wear a light brace for pain release and analgesics will be prescribed.
They can move the elbow, the wrist and the fingers immediately.
After two weeks, they will begin a training program to restore shoulder motion and strength, and they will be asked to take off the brace progressively.
They are allowed to start working and sporting activities when they feel comfortable.
Other Names:
|
|
Active Comparator: Surgical treatment
Patients will undergo surgery to treat their AC joint dislocation.
|
The patient is in a beach-chair position with injured arm slightly out of the table, on a bracket.
The incision is longitudinal, from the distal third of the clavicle to the lateral border of the acromion.
The deltoid is detached anteriorly to present the clavicle and the AC joint.
The width of the hook depends on the depth of the acromion.
The plate will always be 5 holes 3.5mm hook plate (Synthes®), left or right.
The hook is inserted after visual reduction of the AC joint at the posterior border of the distal end of the clavicle, under the acromion.
Reduction is then maintained by a davier and fixation with three 3,5mm cortical screws is achieved.
After washing, deltoid is reinserted.
CC ligaments are not directly repaired.
Wound closure and bracing for two weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional results of injured shoulder on Constant score
Time Frame: 3 months after surgery
|
Based on the patient's subjective and objective answers to the Constant and Murley questionnaire, data are collected and calculated over a 100 points to measure the functional score of the injured shoulder. Also, to measure shoulder strength, the Isoforce system from MDS® is used. |
3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return to professional activities
Time Frame: 3 months after surgery
|
Evaluation of the patient's capacity to return to work and evaluating if those treated surgically return to work faster than the patients with a conservative treatment.
|
3 months after surgery
|
|
Rate of secondary surgery
Time Frame: up to 12 months after surgery
|
The difference on the reoperation rate between the two groups will be analyzed.
|
up to 12 months after surgery
|
|
Social impact on SF-36 scale
Time Frame: 3 months after surgery
|
The social impact of both treatments will be measured with the SF-36 score.
|
3 months after surgery
|
|
Functional difference
Time Frame: 6 months after surgery
|
Using the Constant score, the functional difference between the two groups at 6 months will be measured.
|
6 months after surgery
|
|
Social impact on SF-36 scale
Time Frame: 6 months after surgery
|
The social impact of both treatments will be measured with the SF-36 score.
|
6 months after surgery
|
|
Social impact on SF-36 scale
Time Frame: 12 months after surgery
|
The social impact of both treatments will be measured with the SF-36 score.
|
12 months after surgery
|
|
Radiologic assessment on the Zanca and axillary views
Time Frame: 6 weeks after surgery
|
Zanca view allows control of the superior displacement. It will be expressed in percentage of the CC distance compared to the non-injured side. Axillary view allows control of the posterior displacement. It will be expressed in percentage of the AC distance compared to the non-injured side. Both views will assess degenerative changes, subacromial osteolysis, distal clavicle osteolysis (all expressed in percentage of patients per group). |
6 weeks after surgery
|
|
Rate of complications
Time Frame: up to 12 months after surgery
|
The rate of complications both general and orthopaedic will be described in the in percentage of the number of patients per group.
|
up to 12 months after surgery
|
|
Pain on Visual analog scale (VAS)
Time Frame: 6 weeks after surgery
|
Pain is described with the VAS, which range from 1 to 10.
|
6 weeks after surgery
|
|
Pain on VAS
Time Frame: 3 months after surgery
|
Pain is described with the VAS, which range from 1 to 10.
|
3 months after surgery
|
|
Pain on VAS
Time Frame: 6 months after surgery
|
Pain is described with the VAS, which range from 1 to 10.
|
6 months after surgery
|
|
Pain on VAS
Time Frame: 12 months after surgery
|
Pain is described with the VAS, which range from 1 to 10.
|
12 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karine Sinclair, MD, FRCSC, Hôpital Enfant-Jésus
- Principal Investigator: Luc Bédard, MD, FRCSC, Hôpital Enfant-Jésus
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEJ-337
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acromio-clavicular Joint Dislocation (Type III)
-
University of OxfordWellcome Trust; National Institute for Health Research, United Kingdom; Arthritis...CompletedOsteoarthritis | Rotator Cuff Tear | Avascular Necrosis | Inflammatory Arthritis | Shoulder Dislocation | Dupuytren Contracture | Impingement Syndrome, Shoulder | Elbow Arthropathy | Trigger Digit | Shoulder Arthropathy | Upper Limb Nerve Lesion | Wrist Arthropathy | Fracture Elbow | Dislocations | Fracture, Shoulder | Arthropathy... and other conditions
-
University of British ColumbiaOrthoPediatricsRecruitingHip Dysplasia | Hip Dislocation | Pediatric ALL | Orthopedic Disorder | Hip Disease | Fracture | Implant Complication | Deformity of Limb | Deformity; Bone | Lengthening; Leg | Implant BreakageCanada
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer American Joint Committee on Cancer v8United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedStage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7United States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
Jonsson Comprehensive Cancer CenterRecruitingProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer American Joint Committee on...United States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingUrothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVA... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaTerminatedOropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic... and other conditionsUnited States
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryActive, not recruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
Clinical Trials on Conservative treatment - brace
-
Istanbul Medipol University HospitalHalic UniversityCompletedPulmonary Function | Adolescent Idiopathic ScoliosisTurkey
-
AO Clinical Investigation and Publishing DocumentationTerminatedSingle Level Stable Thoracolumbar Fracture Type AO A3 | Multiple Level Stable Thoracolumbar Fracture Type AO A3Brazil, Germany, Chile, Czechia, Italy, Portugal
-
Seoul National University HospitalCompleted
-
Istituto Ortopedico RizzoliCompleted
-
Bahçeşehir UniversityNot yet recruiting
-
Acibadem UniversityCompletedQuality of Life | Body Image | Brace | Pectus CarinatumTurkey
-
Acibadem UniversityCompletedBrace | Compliance | Pectus CarinatumTurkey
-
The Hospital of VestfoldOslo University HospitalActive, not recruitingHypertension | Obstructive Sleep Apnea | Morbid Obesity | Osteoarthrosis | Type 2 DMNorway
-
Riphah International UniversityNot yet recruiting
-
Konya Beyhekim Training and Research HospitalCompletedLateral Epicondylitis | Tennis ElbowTurkey (Türkiye)